CVS raises 2026 adjusted EPS outlook to $7.9-$8.1

• CVS raised 2026 guidance on its 2Q call, projecting total revenue of at least 414 billion versus at least 405 billion previously.
• Adjusted operating income forecast increased to 16.58 billion-16.92 billion from 15.53 billion-15.87 billion.
• GAAP EPS outlook lifted to 6.84-7.04 from 6.24-6.44; adjusted EPS raised to 7.9-8.1 from 7.3-7.5.
• Cash flow from operations expected at least 11.5 billion, up from at least 9.5 billion; interest expense seen at about 3.1 billion.
• Health Care Benefits MBR forecast tightened to 89.75% ±25 bps from 90.5% ±50 bps; medical membership held near 26 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVS Health Corporation published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein.